Berd D, Cornog J, DeConti R C, Levitt M, Bertino J R
Cancer. 1975 Apr;35(4):1050-4. doi: 10.1002/1097-0142(197504)35:4<1050::aid-cncr2820350406>3.0.co;2-f.
Seventeen patients with Stage III or IV reticulum cell sarcoma were treated with three cycles of a 5-drug regimen between February, 1969 and December, 1970. Of the 17 patients, 9 attained a complete remission and 6 had a parital remission; 2 were considered unevaluable. Recently, the original biopsies from these patients were reclassified according to the criteria of rappaport et al. The results were: diffuse histiocytic--8; nodular histiocytic--2; diffuse mixed--2; nodular mixed--3; diffuse lymphocytic poorly differentiated--1; nodular lymphocytic poorly differentiated--1. Of the 8 patients with diffuse histiocytic lymphoma 6 attained complete remission, 1 had a partial remission, and 1 was unevaluable. One of the 6 with complete remission relapsed at 7 months and died 2 months later. However, the other 5 are alive and in continued unmaintained remission for 55 to 65 months.
1969年2月至1970年12月期间,17例Ⅲ期或Ⅳ期网状细胞肉瘤患者接受了为期三个周期的五药联合方案治疗。17例患者中,9例完全缓解,6例部分缓解,2例疗效无法评估。最近,根据拉帕波特等人的标准对这些患者最初的活检标本进行了重新分类。结果如下:弥漫性组织细胞型——8例;结节性组织细胞型——2例;弥漫性混合型——2例;结节性混合型——3例;弥漫性淋巴细胞低分化型——1例;结节性淋巴细胞低分化型——1例。8例弥漫性组织细胞淋巴瘤患者中,6例完全缓解,1例部分缓解,1例疗效无法评估。6例完全缓解患者中有1例在7个月时复发,2个月后死亡。然而,其他5例仍存活,持续未维持缓解状态达55至65个月。